“Macopharma has initiated in 2018 a strategic transformation. We are a historical major player in blood management and as such have played a key role in bringing innovation and technology to the healthcare professionals around the world. Our engineering capability and industrial strength enabled us to develop and improve available products and performance. These products have always met end user needs in an effective way, and will continue to do so with Quality and Safety at the foremost of our mindset. However, we are initiating today a different approach, focused on therapeutic added value, as well as the impact of our products on the well-being of patients everywhere.
We are all ultimately here to help improve patients outcomes.”